Search company, investor...
BIO-key International company logo

BIO-key International

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price


About BIO-key International

BIO-key International (NASDAQ: BKYI) is a provider of enterprise biometric software and hardware systems and consumer products offering strong, convenient security and user access. The company offers alternatives to passwords, PINs, tokens, and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud.

Headquarters Location

3349 Highway 138 Building A, Suite E

Wall, New Jersey, 07719,

United States


Missing: BIO-key International's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BIO-key International's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BIO-key International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BIO-key International is included in 1 Expert Collection, including Conference Exhibitors.


Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

BIO-key International Patents

BIO-key International has filed 11 patents.

The 3 most popular patent topics include:

  • Biometrics
  • Building automation
  • Home automation
patents chart

Application Date

Grant Date


Related Topics




Image processing, Biometrics, Digital photography, Optical devices, Forensic disciplines


Application Date


Grant Date



Related Topics

Image processing, Biometrics, Digital photography, Optical devices, Forensic disciplines



Latest BIO-key International News

Higher Education Institutions Continue to Select BIO-key's PortalGuard IDaaS Cloud-based Cybersecurity Solution

Jan 30, 2023

A migration from on-premises to PortalGuard IDaaS enables customers to eliminate the hardware costs and resources of on-premises hosting while providing easier IAM and a better user experience. Enabling all users to access resources with one identity quickly drives vital productivity benefits with less friction, better security, and greater access control. Higher Education institutions are attractive, high-value targets for cybercriminals because they hold masses of sensitive data, which is increasingly being accessed remotely. This dynamic stresses budgets and forces IT teams to adopt a more dynamic security response to cyber threats. PortalGuard IDaaS delivers greater flexibility and security options than competitive solutions and provides enterprise-grade protection to safeguard applications and data from increasing threats. "Colleges and Universities looking to improve their security posture and migrate their cybersecurity strategy to the cloud are increasingly choosing PortalGuard IDaaS," said Mark Cochran, President of BIO-key – PortalGuard. "Our robust PortalGuard IDaaS platform delivers secure, flexible, and cost-effective solutions to address these challenges. Our mission is to provide customers with a cost-effective IAM platform that improves processes and security and delivers functionality for an optimal end-user experience." About BIO-key International, Inc. ( ) BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions. BIO-key Safe Harbor Statement All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology and identity access management industries; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted. Engage with BIO-key:

BIO-key International Frequently Asked Questions (FAQ)

  • When was BIO-key International founded?

    BIO-key International was founded in 1993.

  • Where is BIO-key International's headquarters?

    BIO-key International's headquarters is located at 3349 Highway 138, Wall.

  • What is BIO-key International's latest funding round?

    BIO-key International's latest funding round is IPO.

  • How much did BIO-key International raise?

    BIO-key International raised a total of $12M.

  • Who are the investors of BIO-key International?

    Investors of BIO-key International include Iroquois Capital Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.